NextProtein, an agritech startup based in Paris and Tunis, has raised €18 million ($20.7 million) in a Series B fundraising round to develop its insect-based protein production. Led by Swen Capital’s Blue Ocean Fund and BII, the round includes €4 million in debt.
- NextProtein, an agritech startup based in Paris and Tunis, has raised €18 million ($20.7 million) in a Series B fundraising...
- Led by Swen Capital’s Blue Ocean Fund and BII, the round includes €4 million in debt.
- Scaling Insect protein facilities in Tunisia The upcoming facility in Tunisia marks a crucial step for nextProtein, as it aims to...
- Investors show confidence in sustainable protein The funding round signals growing investor confidence in the potential of insect protein to compete...
Keep reading for the full breakdown on Agritech — everything you need to know is covered below.
This capital will establish nextProtein’s second and largest production facility in Tunisia, designed to produce 12,000 tons of insect-based ingredients annually, including 2,500 tons of protein powder.
Scaling Insect protein facilities in Tunisia
The upcoming facility in Tunisia marks a crucial step for nextProtein, as it aims to industrialise insect protein production at competitive cost and scale. The company uses Black Soldier Fly larvae to transform low-value agricultural and food byproducts into three key products: nextMeal (protein powder), nextOil (insect oil), and nextGrow (fertiliser).
These sustainable products target the aquaculture, livestock, and pet food industries, providing alternatives to resource-intensive traditional feeds such as fishmeal and soy.
Investors show confidence in sustainable protein
The funding round signals growing investor confidence in the potential of insect protein to compete with conventional commodities. Alongside new investors, existing backers such as Mirova and RAISE Impact increased their commitments.
NextProtein’s approach emphasises the importance of feedstock flexibility and cost-efficiency to address the energy and scaling challenges common in the industry.
It is anticipated that the new facility’s output will be sufficient to meet the increasing demand in Europe, the Middle East, and Africa (EMEA), thereby reducing time-to-market and optimising supply chains.
NextProtein’s €18 million raise showcases momentum in sustainable protein innovations and highlights Tunisia’s role in emerging agritech solutions.
This fresh capital positions the firm to accelerate the mainstream adoption of insect protein with impressive scale and cost competitiveness.














